Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04886960Phase 2Completed
Phase 2, randomised, double-blind trial in osteoarthritis (OA) (2 arms), sponsored by University of Utah. Primary endpoint: Repeat Allogeneic Intra-articular Injection at 6 months. Started Jul 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04886960.